U-Blot® Research Grade NegalstobartCat. No. WA3220Request quote
Size: 50ug/100ug
Overview
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade NegalstobartCat. No. WA3220U-Blot® Research Grade NecitumumabCat. No. WA3219Request quote
Size: 50ug/100ug
U-Blot® Research Grade NebratamigCat. No. WA3218Request quote
Size: 50ug/100ug
U-Blot® Research Grade nebokitugCat. No. WA3217Request quote
Size: 50ug/100ug
U-Blot® Research Grade nebaprubartCat. No. WA3216Request quote
Size: 50ug/100ug
U-Blot® Research Grade NebacumabCat. No. WA3215Request quote
Size: 50ug/100ug
U-Blot® Research Grade NaxitamabCat. No. WA3214Request quote
Size: 50ug/100ug
U-Blot® Research Grade NaxitamabCat. No. WA3213Request quote
Size: 50ug/100ug
U-Blot® Research Grade NavivumabCat. No. WA3212Request quote
Size: 50ug/100ug
U-Blot® Research Grade NavicixizumabCat. No. WA3211Request quote
Size: 50ug/100ug
U-Blot® Research Grade NavenibartCat. No. WA3210Request quote
Size: 50ug/100ug
U-Blot® Research Grade NatalizumabCat. No. WA3209Request quote
Size: 50ug/100ug
REQUEST A QUOTE
EMAILinfo@mail.ucallm.com
PHONE+(1)-866-986-9598
ONLINE FORMOnline Quote Submission
X+(1)-866-986-9598